Page last updated: 2024-10-30

mesalamine and Heart Disease, Ischemic

mesalamine has been researched along with Heart Disease, Ischemic in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rungoe, C1
Basit, S1
Ranthe, MF1
Wohlfahrt, J1
Langholz, E1
Jess, T1

Other Studies

1 other study available for mesalamine and Heart Disease, Ischemic

ArticleYear
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
    Gut, 2013, Volume: 62, Issue:5

    Topics: Adolescent; Adult; Aged; Atherosclerosis; Case-Control Studies; Cohort Studies; Denmark; Female; Fol

2013